Please assess the completion status of the following clinical trial:

Trial Title: A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women over the age of 40 and less than 45 years old presenting for IVF treatment.~* Willingness to sign informed consent for study randomization.~* Willingness to participate in 2 months pre-IVF treatment.~Exclusion Criteria:~* Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia.~* Family history of significant genetic disease, or factor V Leiden thrombophilia.~* Inability to present for monitoring visits.~* Inability to follow medication instruction.

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- A (Type: EXPERIMENTAL): Dehydroepiandrosterone (DHEA) 25mg tid
- B (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).